Mannkind (MNKD) Gross Profit (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.68% |
| Dec 31, 2025 | 26.27% |
| Sep 30, 2025 | 7.94% |
| Jun 30, 2025 | -3.57% |
| Mar 31, 2025 | 3.64% |
| Dec 31, 2024 | 7.60% |
| Sep 30, 2024 | 0.15% |
| Jun 30, 2024 | 6.95% |
| Mar 31, 2024 | -20.31% |
| Dec 31, 2023 | 107.23% |
| Sep 30, 2023 | 9.26% |
| Jun 30, 2023 | 26.70% |
| Mar 31, 2023 | -56.08% |
| Dec 31, 2022 | 222.51% |
| Sep 30, 2022 | 546.70% |
| Jun 30, 2022 | -486.55% |
| Mar 31, 2022 | 96.41% |
| Dec 31, 2021 | -211.28% |
| Sep 30, 2021 | -2.49% |
| Jun 30, 2021 | 43.81% |
| Mar 31, 2021 | -11.29% |
| Dec 31, 2020 | 25.76% |
| Sep 30, 2020 | 438.25% |
| Jun 30, 2020 | -128.80% |
| Mar 31, 2020 | 6.25% |
| Dec 31, 2019 | 277.54% |
| Sep 30, 2019 | -55.05% |
| Jun 30, 2019 | -130.73% |
| Mar 31, 2019 | 21.58% |
| Dec 31, 2018 | 1,424.34% |
| Sep 30, 2018 | 30.62% |
| Jun 30, 2018 | -121.36% |
| Mar 31, 2018 | -11.27% |
| Dec 31, 2017 | 80.73% |
| Sep 30, 2017 | 13.38% |
| Jun 30, 2017 | -734.06% |
| Mar 31, 2017 | -94.37% |
| Dec 31, 2016 | -94.81% |
| Sep 30, 2016 | 4,005.07% |
| Jun 30, 2016 | 21.73% |
| Mar 31, 2016 | 89.47% |
| Dec 31, 2015 | -9,575.94% |
| Sep 30, 2015 | 91.09% |
| Jun 30, 2015 | -202.39% |